| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |